Companies related to Liquid Chromatography

Serving Science Since 2001

think LC. think KNAUER.

We are one of Monash University Malaysia's key research infrastructure platform

Chromatography is what Restek does, and chromatography is who we are.

Contributing to Society through Science & Technology

Contributing to Society through Science & Technology

The Power of Precision

The most extensive product range for instrumental analysis, life sciences, physical testing, imaging and medical systems

Axcend: HPLC Anywhere

A platform where Science & Technology meets giving raise to unique customer satisfactory output

Molecule separation : opening chemists' innovation horizon, with dramatically reduced environmental impact.

On-site, portable liquid chromatography for cannabis quality control and compliance

Automated Solutions for your Critical Challenges in GC-MS and LC-MS Analysis

Your local gas generation partner.

20+Year Bioanalytical Excellence: GLP PK/PD, ADA/NAb, Multiplex Cytokine, Mass Spec, ELISA, Flow, dPCR, Cell-Based Assay

20+Year Bioanalytical Excellence: GLP PK/PD, ADA/NAb, Multiplex Cytokine, Mass Spec, ELISA, Flow, dPCR, Cell-Based Assay

Minimize size, maximize performance.

Advancing LC-MS-based research with the world's best chromatography.

Your knowledge partner in chromatography and mass spectrometry solutions

Educational and Informative Content for Analytical Scientists

Superior analytics. Reliable results.

Superior analytics. Reliable results.

Gas Generator & Scientific Instrument Manufacture and Support. Chromalytic is a Dürr Technik group brand.

Kemialytics creates knowledge-driven digital environments for pharma, chemistry and biotech.

Kemialytics creates knowledge-driven digital environments for pharma, chemistry and biotech.

Producer of Certified Reference Materials, standards and kits for agriculture, food, textile, and cosmetic sector.

Specialized LC column manufacturer with a focus on unique polymers supports for SEC, HILIC, RP, IC, IEX, and LEX

Accelerating the Development of New Medicines with Targeted Proteomics